Stockreport

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]

LENZ Therapeutics, Inc.  (LENZ) 
PDF Upon FDA approval, commercial launch activities to commence immediately with LNZ100 product availability anticipated in the fourth quarter of 2025 Cash, cash equivale [Read more]